Skip to content

Clinical trials

Phase 3 Carcinoma, Ovarian Epithelial trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 3 Country / region: Belgium Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20111
20161
20171
20181
20191
20202
20211
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting3
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
European Organisation for Research and Treatment of Cancer - EORTC2
ImmunoGen, Inc.2
AbbVie1
Amgen1
CanariaBio Inc.1
Daiichi Sankyo1
EBMT Solid Tumors Working Party1
MEI Pharma, Inc.1
Medical Research Council1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial17
Fallopian Tube Neoplasms12
Ovarian Neoplasms12
Neoplasms2
Peritoneal Neoplasms2
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Embryonal1
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.